| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 ERVK-6 ANK1 ANK3 POTEF SPTA1 LAMA2 ERVK-7 CPOX MMRN1 POTEE THBS2 THBS3 ERVK-8 ERVK-19 ERVK-25 POTEI RIMS2 MUC2 MUC3A EPB41 | 1.69e-09 | 891 | 98 | 21 | GO:0005198 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 9.89e-07 | 37 | 98 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.13e-06 | 38 | 98 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.57e-06 | 130 | 98 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHGA11 SPTA1 PCDH11Y GAS6 PKD1L2 LRP1B ADGRL4 MMRN1 CD93 THBS2 THBS3 SCUBE1 USP32 LRP2 PLCB3 | 3.59e-06 | 749 | 98 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | 3-keto sterol reductase activity | 6.31e-06 | 8 | 98 | 3 | GO:0000253 | |
| GeneOntologyMolecularFunction | carbonyl reductase (NADPH) activity | 9.43e-06 | 9 | 98 | 3 | GO:0004090 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.84e-05 | 11 | 98 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.84e-05 | 11 | 98 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | spectrin binding | 2.26e-05 | 34 | 98 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.94e-05 | 188 | 98 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 4.01e-05 | 14 | 98 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.01e-05 | 14 | 98 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 5.00e-05 | 15 | 98 | 3 | GO:0052650 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.29e-05 | 42 | 98 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 7.42e-05 | 17 | 98 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 7.42e-05 | 17 | 98 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.43e-04 | 21 | 98 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 3.08e-04 | 27 | 98 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 4.23e-04 | 30 | 98 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 5.13e-04 | 32 | 98 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 5.13e-04 | 32 | 98 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 7.89e-04 | 37 | 98 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 8.54e-04 | 38 | 98 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 9.20e-04 | 152 | 98 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.49e-03 | 46 | 98 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.66e-03 | 103 | 98 | 4 | GO:0004725 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.69e-03 | 48 | 98 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 1.80e-03 | 13 | 98 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.63e-03 | 56 | 98 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.74e-03 | 16 | 98 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 3.20e-03 | 60 | 98 | 3 | GO:0016655 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 3.86e-03 | 19 | 98 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.86e-03 | 753 | 98 | 10 | GO:0008134 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 4.25e-03 | 310 | 98 | 6 | GO:0030246 | |
| GeneOntologyMolecularFunction | endonuclease activity | 4.54e-03 | 136 | 98 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 4.71e-03 | 21 | 98 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 5.27e-03 | 430 | 98 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | transition metal ion binding | TRIM46 TET2 ERVK-6 TRPS1 PRND ERVK-7 DCT ZKSCAN5 RTL4 ERVK-8 ERVK-19 MMP9 MUC2 | 5.34e-03 | 1189 | 98 | 13 | GO:0046914 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TRIM46 ANK3 POTEF SYNE1 LAMA2 ALS2 NEDD4 WDR47 POTEE UNC5C LRP2 GOLGA8B PAX6 POTEI RIMS2 MUC3A | 1.91e-06 | 826 | 99 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TRIM46 ANK3 POTEF SYNE1 LAMA2 ALS2 NEDD4 WDR47 POTEE UNC5C LRP2 GOLGA8B PAX6 POTEI RIMS2 | 6.33e-06 | 802 | 99 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TRIM46 ANK3 POTEF SYNE1 LAMA2 ALS2 NEDD4 WDR47 POTEE UNC5C LRP2 GOLGA8B PAX6 POTEI RIMS2 | 8.13e-06 | 819 | 99 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TRIM46 ANK3 POTEF SYNE1 LAMA2 ALS2 NEDD4 WDR47 POTEE UNC5C LRP2 GOLGA8B PAX6 POTEI | 1.32e-05 | 748 | 99 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TRIM46 ANK3 POTEF SYNE1 SPTA1 LAMA2 ALS2 NEDD4 WDR47 POTEE UNC5C LRP2 GOLGA8B PAX6 POTEI RIMS2 MUC3A EPB41 | 1.35e-05 | 1194 | 99 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | axonogenesis | TRIM46 ANK3 POTEF LAMA2 ALS2 WDR47 POTEE UNC5C LRP2 GOLGA8B PAX6 POTEI | 1.71e-05 | 566 | 99 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | DNA integration | 2.96e-05 | 13 | 99 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | axon development | TRIM46 ANK3 POTEF LAMA2 ALS2 WDR47 POTEE UNC5C LRP2 GOLGA8B PAX6 POTEI | 5.83e-05 | 642 | 99 | 12 | GO:0061564 |
| GeneOntologyBiologicalProcess | retinal metabolic process | 1.34e-04 | 21 | 99 | 3 | GO:0042574 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 5.86e-08 | 9 | 99 | 4 | GO:0014731 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 4.63e-04 | 32 | 99 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 4.63e-04 | 32 | 99 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 9.27e-04 | 530 | 99 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 LAMA2 ITGA6 MUC5B MMRN1 ADAMTS10 THBS2 THBS3 MMP9 MUC2 | 1.10e-03 | 656 | 99 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 LAMA2 ITGA6 MUC5B MMRN1 ADAMTS10 THBS2 THBS3 MMP9 MUC2 | 1.12e-03 | 658 | 99 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.27e-03 | 45 | 99 | 3 | GO:1902562 | |
| MousePheno | decreased immunoglobulin level | MAP4K3 DHRS4L1 DHRS4L2 BACH2 PARP14 NEDD4 RCC1L DHRS4 PTPRC CLEC4D MMP9 | 5.68e-07 | 315 | 72 | 11 | MP:0002460 |
| MousePheno | abnormal immunoglobulin level | MAP4K3 DHRS4L1 DHRS4L2 SPTA1 BACH2 LAMA2 PARP14 NEDD4 RCC1L DHRS4 PTPRC CLEC4D MMP9 | 1.84e-06 | 513 | 72 | 13 | MP:0002490 |
| MousePheno | erythroblastosis | 2.59e-06 | 6 | 72 | 3 | MP:0005096 | |
| MousePheno | extramedullary hematopoiesis | 3.70e-06 | 126 | 72 | 7 | MP:0000240 | |
| MousePheno | abnormal IgG level | MAP4K3 DHRS4L1 DHRS4L2 SPTA1 BACH2 LAMA2 NEDD4 RCC1L DHRS4 PTPRC CLEC4D | 4.77e-06 | 392 | 72 | 11 | MP:0020174 |
| MousePheno | abnormal humoral immune response | MAP4K3 DHRS4L1 DHRS4L2 SPTA1 BACH2 LAMA2 PARP14 NEDD4 RCC1L DHRS4 PTPRC CLEC4D MMP9 | 5.20e-06 | 564 | 72 | 13 | MP:0001800 |
| MousePheno | increased erythroblast number | 6.36e-06 | 24 | 72 | 4 | MP:0011178 | |
| MousePheno | abnormal B cell physiology | MAP4K3 DHRS4L1 DHRS4L2 SPTA1 BACH2 LAMA2 PARP14 NEDD4 RCC1L DHRS4 PTPRC CLEC4D MMP9 | 1.34e-05 | 616 | 72 | 13 | MP:0002459 |
| MousePheno | decreased cellular hemoglobin content | 1.53e-05 | 10 | 72 | 3 | MP:0008956 | |
| MousePheno | low mean erythrocyte cell number | 2.79e-05 | 12 | 72 | 3 | MP:0002594 | |
| MousePheno | abnormal cellular hemoglobin content | 2.79e-05 | 12 | 72 | 3 | MP:0008954 | |
| MousePheno | abnormal erythroblast number | 3.00e-05 | 35 | 72 | 4 | MP:0011177 | |
| MousePheno | decreased IgG2 level | 3.47e-05 | 120 | 72 | 6 | MP:0013804 | |
| MousePheno | spherocytosis | 3.61e-05 | 13 | 72 | 3 | MP:0002812 | |
| MousePheno | decreased IgG level | 3.72e-05 | 246 | 72 | 8 | MP:0001805 | |
| MousePheno | increased iron level | 4.18e-05 | 124 | 72 | 6 | MP:0014541 | |
| MousePheno | increased lymphocyte cell number | TET2 CHIA ANK1 SPTA1 BACH2 PARP14 NEDD4 TTC7A MMRN1 PTPN13 PTPRC CLEC4D USP32 MMP9 | 4.64e-05 | 797 | 72 | 14 | MP:0005013 |
| MousePheno | centrally nucleated skeletal muscle fibers | 5.61e-05 | 80 | 72 | 5 | MP:0009404 | |
| MousePheno | abnormal kidney iron level | 5.70e-05 | 15 | 72 | 3 | MP:0008742 | |
| MousePheno | abnormal porphyrin level | 5.70e-05 | 15 | 72 | 3 | MP:0011989 | |
| MousePheno | increased kidney iron level | 5.70e-05 | 15 | 72 | 3 | MP:0010375 | |
| MousePheno | increased porphyrin level | 5.70e-05 | 15 | 72 | 3 | MP:0004147 | |
| MousePheno | increased myeloid cell number | 6.33e-05 | 343 | 72 | 9 | MP:0013663 | |
| MousePheno | abnormal immune serum protein physiology | CHIA MAP4K3 DHRS4L1 DHRS4L2 DDX60 SPTA1 BACH2 LAMA2 MUC5B PARP14 NEDD4 RCC1L DHRS4 PTPN13 PTPRC CLEC4D MMP9 | 6.64e-05 | 1165 | 72 | 17 | MP:0002723 |
| MousePheno | abnormal IgG2 level | 6.74e-05 | 197 | 72 | 7 | MP:0013802 | |
| MousePheno | decreased IgG2a level | 7.09e-05 | 84 | 72 | 5 | MP:0008496 | |
| MousePheno | behavioral despair | 7.52e-05 | 44 | 72 | 4 | MP:0002573 | |
| MousePheno | anisocytosis | 7.52e-05 | 44 | 72 | 4 | MP:0002642 | |
| MousePheno | abnormal erythroblast morphology | 8.22e-05 | 45 | 72 | 4 | MP:0011176 | |
| MousePheno | anisopoikilocytosis | 8.46e-05 | 17 | 72 | 3 | MP:0002641 | |
| MousePheno | decreased spleen iron level | 8.46e-05 | 17 | 72 | 3 | MP:0008808 | |
| MousePheno | abnormal forehead shape | 8.46e-05 | 17 | 72 | 3 | MP:0030045 | |
| MousePheno | abnormal nasal septum morphology | 9.76e-05 | 47 | 72 | 4 | MP:0002239 | |
| MousePheno | abnormal skeletal muscle fiber morphology | 1.07e-04 | 212 | 72 | 7 | MP:0003084 | |
| MousePheno | cleft palate | 1.15e-04 | 289 | 72 | 8 | MP:0000111 | |
| MousePheno | abnormal lymphocyte physiology | MAP4K3 DHRS4L1 DHRS4L2 SPTA1 BACH2 LAMA2 ITGA6 PARP14 NEDD4 RCC1L DHRS4 PTPN13 PTPRC CLEC4D MMP9 | 1.16e-04 | 981 | 72 | 15 | MP:0003945 |
| MousePheno | abnormal IgG2a level | 1.16e-04 | 149 | 72 | 6 | MP:0020176 | |
| MousePheno | oral cleft | 1.21e-04 | 291 | 72 | 8 | MP:0021164 | |
| MousePheno | increased spleen red pulp amount | 1.45e-04 | 52 | 72 | 4 | MP:0008476 | |
| MousePheno | abnormal professional antigen presenting cell physiology | MAP4K3 DHRS4L1 DHRS4L2 SPTA1 BACH2 LAMA2 MUC5B PARP14 NEDD4 CD93 RCC1L DHRS4 PTPRC CLEC4D MMP9 | 1.50e-04 | 1004 | 72 | 15 | MP:0002452 |
| MousePheno | hypochromic anemia | 1.63e-04 | 21 | 72 | 3 | MP:0008387 | |
| MousePheno | decreased susceptibility to induced morbidity/mortality | 2.13e-04 | 106 | 72 | 5 | MP:0009764 | |
| MousePheno | abnormal palate morphology | 2.36e-04 | 321 | 72 | 8 | MP:0003755 | |
| MousePheno | small maxilla | 2.38e-04 | 59 | 72 | 4 | MP:0004540 | |
| MousePheno | abnormal forehead morphology | 2.45e-04 | 24 | 72 | 3 | MP:0030031 | |
| MousePheno | abnormal external nares morphology | 2.59e-04 | 5 | 72 | 2 | MP:0002235 | |
| MousePheno | abnormal nephron morphology | 3.24e-04 | 426 | 72 | 9 | MP:0003881 | |
| MousePheno | small mandible | 3.24e-04 | 116 | 72 | 5 | MP:0004592 | |
| MousePheno | kyphoscoliosis | 3.51e-04 | 27 | 72 | 3 | MP:0000069 | |
| MousePheno | microcytic anemia | 3.51e-04 | 27 | 72 | 3 | MP:0002810 | |
| MousePheno | abnormal myelopoiesis | 3.65e-04 | 119 | 72 | 5 | MP:0001601 | |
| MousePheno | abnormal temporal bone morphology | 3.66e-04 | 66 | 72 | 4 | MP:0005272 | |
| MousePheno | small temporal bone squamous part | 3.87e-04 | 6 | 72 | 2 | MP:0030121 | |
| MousePheno | abnormal cranial neural crest cell morphology | 3.87e-04 | 6 | 72 | 2 | MP:0012754 | |
| MousePheno | increased liver iron level | 3.91e-04 | 28 | 72 | 3 | MP:0008807 | |
| MousePheno | micrognathia | 4.11e-04 | 68 | 72 | 4 | MP:0002639 | |
| MousePheno | abnormal basicranium morphology | 4.25e-04 | 123 | 72 | 5 | MP:0010029 | |
| MousePheno | thrombocytosis | 4.57e-04 | 125 | 72 | 5 | MP:0005505 | |
| MousePheno | poikilocytosis | 5.31e-04 | 31 | 72 | 3 | MP:0002643 | |
| MousePheno | polychromatophilia | 5.31e-04 | 31 | 72 | 3 | MP:0005097 | |
| MousePheno | perinatal lethality | COL2A1 TET2 ANK1 SYNE1 SPTA1 TRPS1 LAMA2 ITGA6 RUNX1T1 SIX1 NEDD4 SCUBE1 LRP2 PAX6 SIX2 | 5.38e-04 | 1130 | 72 | 15 | MP:0002081 |
| MousePheno | increased depression-related behavior | 5.38e-04 | 73 | 72 | 4 | MP:0014414 | |
| MousePheno | abnormal erythropoiesis | 5.67e-04 | 131 | 72 | 5 | MP:0000245 | |
| MousePheno | abnormal proerythroblast morphology | 5.67e-04 | 74 | 72 | 4 | MP:0002416 | |
| MousePheno | abnormal nose morphology | 5.82e-04 | 201 | 72 | 6 | MP:0002233 | |
| MousePheno | abnormal spleen iron level | 5.84e-04 | 32 | 72 | 3 | MP:0008739 | |
| MousePheno | abnormal nasal cavity morphology | 5.84e-04 | 32 | 72 | 3 | MP:0002237 | |
| MousePheno | abnormal respiratory system physiology | COL2A1 SPTA1 BACH2 TRPS1 LAMA2 MUC5B SIX1 PTPRC CLEC4D LRP2 GOLGA8B PAX6 MMP9 | 5.92e-04 | 897 | 72 | 13 | MP:0002133 |
| MousePheno | abnormal Purkinje cell morphology | 6.30e-04 | 204 | 72 | 6 | MP:0000877 | |
| MousePheno | short snout | 6.72e-04 | 136 | 72 | 5 | MP:0000445 | |
| MousePheno | decreased submandibular gland size | 7.18e-04 | 8 | 72 | 2 | MP:0009520 | |
| MousePheno | prominent forehead | 7.18e-04 | 8 | 72 | 2 | MP:0030049 | |
| MousePheno | abnormal leukocyte physiology | MAP4K3 DHRS4L1 DHRS4L2 SPTA1 BACH2 LAMA2 ITGA6 MUC5B PARP14 NEDD4 CD93 RCC1L DHRS4 PTPN13 PTPRC CLEC4D MMP9 | 7.38e-04 | 1425 | 72 | 17 | MP:0002442 |
| MousePheno | reticulocytosis | 7.62e-04 | 80 | 72 | 4 | MP:0002640 | |
| MousePheno | abnormal skeletal muscle fiber size | 7.66e-04 | 140 | 72 | 5 | MP:0009398 | |
| MousePheno | premature death | TET2 ANK1 ANK3 SPTA1 LAMA2 MUC5B RUNX1T1 TTC7A ZNF106 THBS2 PTPRC GOLGA8B PAX6 RIMS2 | 8.21e-04 | 1051 | 72 | 14 | MP:0002083 |
| MousePheno | abnormal hindbrain morphology | 8.25e-04 | 485 | 72 | 9 | MP:0000841 | |
| MousePheno | abnormal liver iron level | 8.28e-04 | 36 | 72 | 3 | MP:0008738 | |
| MousePheno | hemolytic anemia | 8.28e-04 | 36 | 72 | 3 | MP:0001585 | |
| MousePheno | neonatal lethality, incomplete penetrance | 8.40e-04 | 298 | 72 | 7 | MP:0011088 | |
| MousePheno | abnormal dendritic cell morphology | 8.43e-04 | 143 | 72 | 5 | MP:0005461 | |
| MousePheno | abnormal cerebellum morphology | 8.46e-04 | 389 | 72 | 8 | MP:0000849 | |
| MousePheno | small snout | 8.70e-04 | 144 | 72 | 5 | MP:0030190 | |
| MousePheno | abnormal maxilla morphology | 8.70e-04 | 144 | 72 | 5 | MP:0000455 | |
| MousePheno | abnormal cerebellar cortex morphology | 8.74e-04 | 300 | 72 | 7 | MP:0004097 | |
| MousePheno | abnormal iron level | 8.90e-04 | 218 | 72 | 6 | MP:0001770 | |
| MousePheno | abnormal immune cell physiology | MAP4K3 DHRS4L1 DHRS4L2 SPTA1 BACH2 LAMA2 ITGA6 MUC5B PARP14 NEDD4 CD93 RCC1L DHRS4 PTPN13 PTPRC CLEC4D MMP9 | 8.99e-04 | 1450 | 72 | 17 | MP:0001819 |
| MousePheno | abnormal ciliary process morphology | 9.20e-04 | 9 | 72 | 2 | MP:0014164 | |
| MousePheno | absent nasal septum | 9.20e-04 | 9 | 72 | 2 | MP:0004872 | |
| MousePheno | abnormal face development | 9.20e-04 | 9 | 72 | 2 | MP:0030313 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 9.34e-04 | 220 | 72 | 6 | MP:0000875 | |
| MousePheno | abnormal cell-mediated immunity | MAP4K3 DHRS4L1 DHRS4L2 SPTA1 BACH2 LAMA2 ITGA6 MUC5B PARP14 NEDD4 CD93 RCC1L DHRS4 PTPN13 PTPRC CLEC4D MMP9 | 9.94e-04 | 1463 | 72 | 17 | MP:0002421 |
| MousePheno | abnormal iron homeostasis | 1.00e-03 | 223 | 72 | 6 | MP:0005637 | |
| MousePheno | abnormal T-helper 2 cell morphology | 1.05e-03 | 39 | 72 | 3 | MP:0002434 | |
| MousePheno | decreased mean corpuscular volume | 1.05e-03 | 225 | 72 | 6 | MP:0002591 | |
| MousePheno | perinatal lethality, incomplete penetrance | 1.07e-03 | 503 | 72 | 9 | MP:0011090 | |
| MousePheno | abnormal muscle fiber morphology | 1.11e-03 | 406 | 72 | 8 | MP:0004087 | |
| MousePheno | abnormal skeletal muscle morphology | 1.14e-03 | 508 | 72 | 9 | MP:0000759 | |
| MousePheno | schistocytosis | 1.15e-03 | 10 | 72 | 2 | MP:0000314 | |
| MousePheno | increased erythrocyte protoporphyrin level | 1.15e-03 | 10 | 72 | 2 | MP:0011188 | |
| Domain | EGF_CA | 1.07e-08 | 122 | 94 | 9 | SM00179 | |
| Domain | EGF_CA | 1.17e-08 | 86 | 94 | 8 | PF07645 | |
| Domain | EGF-like_Ca-bd_dom | 1.24e-08 | 124 | 94 | 9 | IPR001881 | |
| Domain | EGF | GAS6 LAMA2 LRP1B ADGRL4 MMRN1 CD93 THBS2 THBS3 SCUBE1 LRP2 MUC3A | 2.73e-08 | 235 | 94 | 11 | SM00181 |
| Domain | EGF-like_dom | GAS6 LAMA2 LRP1B ADGRL4 MMRN1 CD93 THBS2 THBS3 SCUBE1 LRP2 MUC3A | 4.94e-08 | 249 | 94 | 11 | IPR000742 |
| Domain | EGF-like_CS | GAS6 LAMA2 LRP1B ADGRL4 MMRN1 CD93 THBS2 THBS3 SCUBE1 LRP2 MUC3A | 7.98e-08 | 261 | 94 | 11 | IPR013032 |
| Domain | EGF_2 | GAS6 LAMA2 LRP1B ADGRL4 MMRN1 CD93 THBS2 THBS3 SCUBE1 LRP2 MUC3A | 9.31e-08 | 265 | 94 | 11 | PS01186 |
| Domain | cEGF | 1.75e-07 | 26 | 94 | 5 | PF12662 | |
| Domain | cEGF | 1.75e-07 | 26 | 94 | 5 | IPR026823 | |
| Domain | EGF_3 | 2.95e-07 | 235 | 94 | 10 | PS50026 | |
| Domain | EGF_Ca-bd_CS | 5.80e-07 | 97 | 94 | 7 | IPR018097 | |
| Domain | EGF_CA | 6.66e-07 | 99 | 94 | 7 | PS01187 | |
| Domain | VWFC_1 | 9.66e-07 | 36 | 94 | 5 | PS01208 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.06e-06 | 106 | 94 | 7 | IPR000152 | |
| Domain | VWFC_2 | 1.28e-06 | 38 | 94 | 5 | PS50184 | |
| Domain | VWC | 1.28e-06 | 38 | 94 | 5 | SM00214 | |
| Domain | VWF_dom | 2.13e-06 | 42 | 94 | 5 | IPR001007 | |
| Domain | SIX1_SD | 4.26e-06 | 7 | 94 | 3 | IPR031701 | |
| Domain | SIX1_SD | 4.26e-06 | 7 | 94 | 3 | PF16878 | |
| Domain | EGF_1 | 5.54e-06 | 255 | 94 | 9 | PS00022 | |
| Domain | ZU5 | 1.01e-05 | 9 | 94 | 3 | SM00218 | |
| Domain | VWC | 1.12e-05 | 28 | 94 | 4 | PF00093 | |
| Domain | ASX_HYDROXYL | 1.13e-05 | 100 | 94 | 6 | PS00010 | |
| Domain | ZU5 | 1.44e-05 | 10 | 94 | 3 | PS51145 | |
| Domain | ConA-like_dom | 1.47e-05 | 219 | 94 | 8 | IPR013320 | |
| Domain | Nab_N | 2.51e-05 | 2 | 94 | 2 | PD342192 | |
| Domain | NAB_co-repressor_dom | 2.51e-05 | 2 | 94 | 2 | IPR006989 | |
| Domain | Nab_N | 2.51e-05 | 2 | 94 | 2 | IPR006988 | |
| Domain | NCD2 | 2.51e-05 | 2 | 94 | 2 | PF04905 | |
| Domain | NCD1 | 2.51e-05 | 2 | 94 | 2 | PF04904 | |
| Domain | ZU5 | 2.63e-05 | 12 | 94 | 3 | PF00791 | |
| Domain | ZU5_dom | 2.63e-05 | 12 | 94 | 3 | IPR000906 | |
| Domain | PTPc | 3.13e-05 | 36 | 94 | 4 | SM00194 | |
| Domain | EGF | 4.19e-05 | 126 | 94 | 6 | PF00008 | |
| Domain | TIL_dom | 4.32e-05 | 14 | 94 | 3 | IPR002919 | |
| Domain | TYR_PHOSPHATASE_PTP | 4.32e-05 | 39 | 94 | 4 | PS50055 | |
| Domain | PTPase_domain | 5.28e-05 | 41 | 94 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 5.28e-05 | 41 | 94 | 4 | PF00102 | |
| Domain | Actin_CS | 6.59e-05 | 16 | 94 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 7.98e-05 | 17 | 94 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 9.54e-05 | 18 | 94 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.13e-04 | 19 | 94 | 3 | PS01132 | |
| Domain | Growth_fac_rcpt_ | 1.37e-04 | 156 | 94 | 6 | IPR009030 | |
| Domain | Laminin_G | 2.07e-04 | 58 | 94 | 4 | IPR001791 | |
| Domain | PTPc_motif | 2.22e-04 | 59 | 94 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.22e-04 | 59 | 94 | 4 | IPR003595 | |
| Domain | TSP_3 | 2.48e-04 | 5 | 94 | 2 | PF02412 | |
| Domain | TSP3 | 2.48e-04 | 5 | 94 | 2 | PS51234 | |
| Domain | TSP_CTER | 2.48e-04 | 5 | 94 | 2 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 2.48e-04 | 5 | 94 | 2 | IPR017897 | |
| Domain | TSP_type-3_rpt | 2.48e-04 | 5 | 94 | 2 | IPR028974 | |
| Domain | - | 2.48e-04 | 5 | 94 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 2.48e-04 | 5 | 94 | 2 | IPR008859 | |
| Domain | TSP_C | 2.48e-04 | 5 | 94 | 2 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 2.48e-04 | 5 | 94 | 2 | IPR003367 | |
| Domain | DEATH | 3.31e-04 | 27 | 94 | 3 | SM00005 | |
| Domain | WxxW_domain | 3.71e-04 | 6 | 94 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 3.71e-04 | 6 | 94 | 2 | PF13330 | |
| Domain | Actin | 5.01e-04 | 31 | 94 | 3 | IPR004000 | |
| Domain | Actin | 5.01e-04 | 31 | 94 | 3 | PF00022 | |
| Domain | ACTIN | 5.01e-04 | 31 | 94 | 3 | SM00268 | |
| Domain | Death | 6.04e-04 | 33 | 94 | 3 | PF00531 | |
| Domain | Ank_2 | 7.61e-04 | 215 | 94 | 6 | PF12796 | |
| Domain | Death_domain | 9.17e-04 | 38 | 94 | 3 | IPR000488 | |
| Domain | DEATH_DOMAIN | 9.17e-04 | 38 | 94 | 3 | PS50017 | |
| Domain | TYR_PHOSPHATASE_1 | 9.32e-04 | 86 | 94 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 9.73e-04 | 87 | 94 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 9.73e-04 | 87 | 94 | 4 | PS50056 | |
| Domain | Ank | 1.03e-03 | 228 | 94 | 6 | PF00023 | |
| Domain | Ank_3 | 1.10e-03 | 10 | 94 | 2 | PF13606 | |
| Domain | - | 1.20e-03 | 92 | 94 | 4 | 3.90.190.10 | |
| Domain | - | 1.25e-03 | 93 | 94 | 4 | 1.10.533.10 | |
| Domain | Laminin_G_1 | 1.34e-03 | 11 | 94 | 2 | PF00054 | |
| Domain | - | 1.35e-03 | 95 | 94 | 4 | 2.60.120.200 | |
| Domain | DEATH-like_dom | 1.57e-03 | 99 | 94 | 4 | IPR011029 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.57e-03 | 99 | 94 | 4 | IPR029021 | |
| Domain | - | 1.59e-03 | 248 | 94 | 6 | 1.25.40.20 | |
| Domain | EGF_dom | 1.60e-03 | 12 | 94 | 2 | IPR024731 | |
| Domain | C8 | 1.60e-03 | 12 | 94 | 2 | PF08742 | |
| Domain | EGF_3 | 1.60e-03 | 12 | 94 | 2 | PF12947 | |
| Domain | TIL | 1.60e-03 | 12 | 94 | 2 | PF01826 | |
| Domain | ANK | 1.69e-03 | 251 | 94 | 6 | SM00248 | |
| Domain | ANK_REPEAT | 1.75e-03 | 253 | 94 | 6 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.79e-03 | 254 | 94 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.79e-03 | 254 | 94 | 6 | PS50297 | |
| Domain | Unchr_dom_Cys-rich | 1.89e-03 | 13 | 94 | 2 | IPR014853 | |
| Domain | C8 | 1.89e-03 | 13 | 94 | 2 | SM00832 | |
| Domain | Ankyrin_rpt | 2.09e-03 | 262 | 94 | 6 | IPR002110 | |
| Domain | Ldl_recept_b | 2.19e-03 | 14 | 94 | 2 | PF00058 | |
| Domain | LDLRB | 2.19e-03 | 14 | 94 | 2 | PS51120 | |
| Domain | CNH | 2.19e-03 | 14 | 94 | 2 | SM00036 | |
| Domain | LY | 2.52e-03 | 15 | 94 | 2 | SM00135 | |
| Domain | CNH | 2.52e-03 | 15 | 94 | 2 | PF00780 | |
| Domain | CNH | 2.52e-03 | 15 | 94 | 2 | PS50219 | |
| Domain | CNH_dom | 2.52e-03 | 15 | 94 | 2 | IPR001180 | |
| Domain | LDLR_classB_rpt | 2.52e-03 | 15 | 94 | 2 | IPR000033 | |
| Domain | VWF_type-D | 2.87e-03 | 16 | 94 | 2 | IPR001846 | |
| Domain | MAM_1 | 2.87e-03 | 16 | 94 | 2 | PS00740 | |
| Domain | VWFD | 2.87e-03 | 16 | 94 | 2 | PS51233 | |
| Domain | VWD | 2.87e-03 | 16 | 94 | 2 | SM00216 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.85e-05 | 84 | 64 | 5 | M7098 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.34e-04 | 109 | 64 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.46e-04 | 111 | 64 | 5 | M27416 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.15e-04 | 26 | 64 | 3 | M27483 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.25e-04 | 66 | 64 | 4 | M18 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.45e-04 | 575 | 64 | 10 | M29853 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.53e-04 | 68 | 64 | 4 | M27303 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 2.70e-04 | 28 | 64 | 3 | MM15188 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 3.00e-04 | 29 | 64 | 3 | M29808 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.66e-04 | 31 | 64 | 3 | M877 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 ANK1 ANK3 SPTA1 NAB1 NAB2 LAMA2 ITGA6 SIX1 DCT PTPRC UNC5C MED21 PAX6 MMP9 SIX2 | 5.14e-04 | 1432 | 64 | 16 | M509 |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 6.28e-04 | 532 | 64 | 9 | M27870 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 27323117 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 10333503 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 20525226 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 12680773 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 16406282 | ||
| Pubmed | Molecular and functional evolution of human DHRS2 and DHRS4 duplicated genes. | 9.21e-08 | 4 | 100 | 3 | 23036705 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.30e-07 | 5 | 100 | 3 | 12629516 | |
| Pubmed | Genome-wide association identifies ATOH7 as a major gene determining human optic disc size. | 2.41e-07 | 19 | 100 | 4 | 20395239 | |
| Pubmed | FGF-induced Pea3 transcription factors program the genetic landscape for cell fate determination. | 6.54e-07 | 24 | 100 | 4 | 30188892 | |
| Pubmed | 2.63e-06 | 210 | 100 | 7 | 16537572 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 2.73e-06 | 10 | 100 | 3 | 22159418 | |
| Pubmed | 4.98e-06 | 12 | 100 | 3 | 14557543 | ||
| Pubmed | WD40-repeat 47, a microtubule-associated protein, is essential for brain development and autophagy. | 5.43e-06 | 40 | 100 | 4 | 29078390 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 7.96e-06 | 94 | 100 | 5 | 21542922 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 33281191 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34763455 | ||
| Pubmed | Increased cation permeability in mutant mouse red blood cells with defective membrane skeletons. | 8.18e-06 | 2 | 100 | 2 | 7492791 | |
| Pubmed | Alternative transcription initiation and splicing variants of the DHRS4 gene cluster. | 8.18e-06 | 2 | 100 | 2 | 18754758 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 1356891 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 8.18e-06 | 2 | 100 | 2 | 19669888 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28694211 | ||
| Pubmed | Corneal stromal cells (keratocytes) express thrombospondins 2 and 3 in wound repair phenotype. | 8.18e-06 | 2 | 100 | 2 | 11943589 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12030330 | ||
| Pubmed | Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues. | 8.18e-06 | 2 | 100 | 2 | 10329465 | |
| Pubmed | Novel mutants of NAB corepressors enhance activation by Egr transactivators. | 8.18e-06 | 2 | 100 | 2 | 9774344 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 33021341 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31653825 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15473316 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17484881 | ||
| Pubmed | α-ketoglutarate is associated with delayed wound healing in diabetes. | 8.18e-06 | 2 | 100 | 2 | 26921880 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12130521 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 29773648 | ||
| Pubmed | Resistance to malaria in ankyrin and spectrin deficient mice. | 8.18e-06 | 2 | 100 | 2 | 1832936 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9060628 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17230527 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 8.18e-06 | 2 | 100 | 2 | 9460924 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 27600920 | ||
| Pubmed | [Interleukin-1beta induces MUC2/MUC5B gene expression in human nasal epithelial cells]. | 8.18e-06 | 2 | 100 | 2 | 20873538 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 20339087 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 33556457 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 9.51e-06 | 168 | 100 | 6 | 30631154 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.02e-05 | 15 | 100 | 3 | 16824795 | |
| Pubmed | ERK1 and ERK2 regulate chondrocyte terminal differentiation during endochondral bone formation. | 1.52e-05 | 17 | 100 | 3 | 25401279 | |
| Pubmed | 1.82e-05 | 18 | 100 | 3 | 20347762 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.82e-05 | 18 | 100 | 3 | 18834073 | |
| Pubmed | 1.82e-05 | 18 | 100 | 3 | 28701737 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 7789273 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 9705320 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 9524190 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 29861105 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 23376040 | ||
| Pubmed | Astrocyte-derived thrombospondin-2 is critical for the repair of the blood-brain barrier. | 2.45e-05 | 3 | 100 | 2 | 21704005 | |
| Pubmed | A hierarchy of ankyrin-spectrin complexes clusters sodium channels at nodes of Ranvier. | 2.45e-05 | 3 | 100 | 2 | 25362473 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 20585040 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 7803849 | ||
| Pubmed | MicroRNA-129 and -335 Promote Diabetic Wound Healing by Inhibiting Sp1-Mediated MMP-9 Expression. | 2.45e-05 | 3 | 100 | 2 | 29748291 | |
| Pubmed | Ankyrin facilitates intracellular trafficking of alpha1-Na+-K+-ATPase in polarized cells. | 2.45e-05 | 3 | 100 | 2 | 18768923 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 31092423 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 2.45e-05 | 3 | 100 | 2 | 1459996 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 22891334 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 10654606 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 31789389 | ||
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 2.45e-05 | 3 | 100 | 2 | 8400410 | |
| Pubmed | Role of collagen type II and perlecan in skeletal development. | 2.45e-05 | 3 | 100 | 2 | 12814946 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 18455130 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 22197999 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19718741 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 17652716 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 9373030 | ||
| Pubmed | Spectrin's E2/E3 ubiquitin conjugating/ligating activity is diminished in sickle cells. | 2.45e-05 | 3 | 100 | 2 | 15929114 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 1385865 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 6763106 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 10516026 | ||
| Pubmed | Nab proteins are essential for peripheral nervous system myelination. | 2.45e-05 | 3 | 100 | 2 | 16136673 | |
| Pubmed | Molecular effects of Eya1 domain mutations causing organ defects in BOR syndrome. | 2.45e-05 | 3 | 100 | 2 | 11734542 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 10893266 | ||
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 2.45e-05 | 3 | 100 | 2 | 33410423 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 15735644 | ||
| Pubmed | Ankyrin-independent membrane protein-binding sites for brain and erythrocyte spectrin. | 2.45e-05 | 3 | 100 | 2 | 2971657 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 26656045 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 2.45e-05 | 3 | 100 | 2 | 17101985 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 30362313 | ||
| Pubmed | AML1-ETO interacts with Sp1 and antagonizes Sp1 transactivity through RUNT domain. | 2.45e-05 | 3 | 100 | 2 | 18519037 | |
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 2.45e-05 | 3 | 100 | 2 | 34289389 | |
| Pubmed | 2.54e-05 | 20 | 100 | 3 | 18723693 | ||
| Pubmed | 2.59e-05 | 59 | 100 | 4 | 26371508 | ||
| Pubmed | Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes. | 2.71e-05 | 121 | 100 | 5 | 8827514 | |
| Pubmed | Stromal netrin 1 coordinates renal arteriogenesis and mural cell differentiation. | 3.41e-05 | 22 | 100 | 3 | 37823339 | |
| Pubmed | 4.19e-05 | 322 | 100 | 7 | 26514267 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 12186868 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 8668170 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 25638393 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 4.89e-05 | 4 | 100 | 2 | 22269464 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 379653 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 33620149 | ||
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 4.89e-05 | 4 | 100 | 2 | 6338048 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 23807779 | ||
| Pubmed | Six family genes control the proliferation and differentiation of muscle satellite cells. | 4.89e-05 | 4 | 100 | 2 | 20696153 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 20529870 | ||
| Cytoband | 1p33-p32 | 1.64e-04 | 9 | 99 | 2 | 1p33-p32 | |
| Cytoband | 2q21.1 | 2.75e-04 | 58 | 99 | 3 | 2q21.1 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.75e-05 | 13 | 73 | 3 | 685 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 7.97e-05 | 21 | 73 | 3 | 813 | |
| GeneFamily | CD molecules|Mucins | 7.97e-05 | 21 | 73 | 3 | 648 | |
| GeneFamily | SINE class homeoboxes | 2.39e-04 | 6 | 73 | 2 | 525 | |
| GeneFamily | Ankyrin repeat domain containing | 4.35e-04 | 242 | 73 | 6 | 403 | |
| GeneFamily | Low density lipoprotein receptors | 1.22e-03 | 13 | 73 | 2 | 634 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 3.59e-03 | 76 | 73 | 3 | 743 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN | 8.49e-06 | 200 | 95 | 7 | M8208 | |
| Coexpression | STEINER_ERYTHROCYTE_MEMBRANE_GENES | 1.63e-05 | 14 | 95 | 3 | M2442 | |
| Coexpression | NABA_MATRISOME | COL2A1 GAS6 LAMA2 MUC5B MMRN1 ADAMTS10 THBS2 THBS3 SCUBE1 CLEC4D PXDNL MMP9 MUC2 MUC3A | 1.94e-05 | 1026 | 95 | 14 | M5889 |
| Coexpression | VANLOO_SP3_TARGETS_DN | 3.72e-05 | 103 | 95 | 5 | MM919 | |
| Coexpression | NABA_CORE_MATRISOME | 6.52e-05 | 275 | 95 | 7 | M5884 | |
| Coexpression | SENESE_HDAC2_TARGETS_UP | 6.57e-05 | 116 | 95 | 5 | M4113 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.10e-05 | 196 | 95 | 6 | M3008 | |
| Coexpression | GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP | 8.57e-05 | 198 | 95 | 6 | M8131 | |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_DN | 9.05e-05 | 200 | 95 | 6 | M3399 | |
| Coexpression | GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP | 9.05e-05 | 200 | 95 | 6 | M3251 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 1.01e-04 | 398 | 95 | 8 | M7514 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 184 | 95 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 184 | 95 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-07 | 184 | 95 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 1.55e-07 | 187 | 95 | 7 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.93e-07 | 193 | 95 | 7 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 1.93e-07 | 193 | 95 | 7 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.93e-07 | 193 | 95 | 7 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.93e-07 | 193 | 95 | 7 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.93e-07 | 193 | 95 | 7 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-07 | 193 | 95 | 7 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 2.37e-07 | 199 | 95 | 7 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 2.45e-07 | 200 | 95 | 7 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.33e-07 | 128 | 95 | 6 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 160 | 95 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 160 | 95 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 176 | 95 | 6 | fc51e4dcad5456c229d76fdcb9a80c4c79eacf3f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 178 | 95 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.60e-06 | 182 | 95 | 6 | dc29e8735c3562ce32322351d28f7d9709208ebf | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.95e-06 | 186 | 95 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-06 | 188 | 95 | 6 | a37edd8f9e4a4e336b5acbb0407d3d275975cee8 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.14e-06 | 188 | 95 | 6 | b9c5d573fc5ab0f7f38c55d006f9576634b05462 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.33e-06 | 190 | 95 | 6 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.44e-06 | 191 | 95 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-06 | 192 | 95 | 6 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-06 | 192 | 95 | 6 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.54e-06 | 192 | 95 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.65e-06 | 193 | 95 | 6 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.65e-06 | 193 | 95 | 6 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 3.76e-06 | 194 | 95 | 6 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.87e-06 | 195 | 95 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.87e-06 | 195 | 95 | 6 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.87e-06 | 195 | 95 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.87e-06 | 195 | 95 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.11e-06 | 197 | 95 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.11e-06 | 197 | 95 | 6 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.11e-06 | 197 | 95 | 6 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 4.11e-06 | 197 | 95 | 6 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.11e-06 | 197 | 95 | 6 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-06 | 198 | 95 | 6 | 953630dbe3154b1b102b87de0feca2cbf124eabe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-06 | 198 | 95 | 6 | 8e45551224fbb30c0658ad47dd98335ecf165437 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.35e-06 | 199 | 95 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.35e-06 | 199 | 95 | 6 | edb68a4f622a494f22fd7b25bc40ae0d58456cdb | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.35e-06 | 199 | 95 | 6 | 448dd5a27d57627468c6b8347f1b6b1005aea004 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.35e-06 | 199 | 95 | 6 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.35e-06 | 199 | 95 | 6 | 45f9c03d2ed2d98d66086fb0251bd24e30c6f775 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | 0eccf41edefc3b8b5d0316f57d5ba572949aec2b | |
| ToppCell | Lung_Parenchyma-Control-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.48e-06 | 200 | 95 | 6 | 41ac6adbf61763aa8a81a0ed586c4a5542a42cc5 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.48e-06 | 200 | 95 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Biopsy_Control_(H.)-Endothelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.48e-06 | 200 | 95 | 6 | 6a9b6a4b4f204598290ae21c87ddb42ac95dfc4c | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.48e-06 | 200 | 95 | 6 | 5109b417c066ecca0252008206b4f4b7a14c8702 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.48e-06 | 200 | 95 | 6 | 9e5627e11288713aa9b622aae40e849dd6eacd29 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Oprk1_(Claustrum_cortex)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.13e-06 | 128 | 95 | 5 | 7e3f5cea91af005f08d8e9340fb8630bf1c887c3 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.13e-06 | 128 | 95 | 5 | a876303c852db2af9418d1a1711d7c950805018a | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Oprk1_(Claustrum_cortex)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.13e-06 | 128 | 95 | 5 | 388062f840fd04cb8087f27a9a78e7a192920e3e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.99e-05 | 154 | 95 | 5 | d22902d2922784583f7016453768ed05b14b965e | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Matrix_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.99e-05 | 154 | 95 | 5 | 928f49839b046b90c2f942458f3e365ddc4e0bc9 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 162 | 95 | 5 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 162 | 95 | 5 | dddf7a3901ae59e3494d8a6740db0fa15cc96d47 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 162 | 95 | 5 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 162 | 95 | 5 | ad974426039f4952c59d27167eac24dc6ce63f5e | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 162 | 95 | 5 | 4e7e565091bce227d794a36af2e5dfc4a791efad | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 162 | 95 | 5 | 2a4e09545e9874519f0f56e81065104987d81cd6 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 163 | 95 | 5 | 1eec7f5e5fed05fa21d3f81db588f10605f08ea7 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 164 | 95 | 5 | f3772227f5aa75a3672d945f8d5bf3fa0b4e456b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 165 | 95 | 5 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 165 | 95 | 5 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 166 | 95 | 5 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 166 | 95 | 5 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 2.94e-05 | 167 | 95 | 5 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.94e-05 | 167 | 95 | 5 | a90f905ef38437752e2b0b71bd0322a184de1861 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 168 | 95 | 5 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 169 | 95 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythroid_lineage_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.20e-05 | 170 | 95 | 5 | 288014dedda8babc51fe08e48a55e68d83e1b1d2 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 172 | 95 | 5 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 172 | 95 | 5 | 6004327045f03d832fdabe6cb2f8b1b1db57789a | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 172 | 95 | 5 | 31c5710fd7ebb221e703545595f5ec0ee3a32bcf | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 172 | 95 | 5 | 4790323a072cfe76127d704665a42c09601d84be | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 3.38e-05 | 172 | 95 | 5 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 174 | 95 | 5 | 81ab196e36cac2a7974d6e3fe457efffddfd03bb | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-05 | 175 | 95 | 5 | cd42020fe57afeaadfbd3ef6d7375e66d71e9669 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-05 | 175 | 95 | 5 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 176 | 95 | 5 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | facs-Heart-LV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 176 | 95 | 5 | 483e36d9bb7268bf179e69a65e1a0be099035162 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 3.87e-05 | 177 | 95 | 5 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | Endothelial|World / shred by cell class for turbinate | 4.09e-05 | 179 | 95 | 5 | 052b2681974be00efb8503fa4e2c85d91d5ebd06 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 181 | 95 | 5 | 709e9c7a60d5f98635b99895ce30bb87a9f7376d | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 182 | 95 | 5 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 182 | 95 | 5 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 182 | 95 | 5 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.54e-05 | 183 | 95 | 5 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 4.54e-05 | 183 | 95 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 4.54e-05 | 183 | 95 | 5 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | Endothelial-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.54e-05 | 183 | 95 | 5 | 2c3f2c25c38f0598b4787d2ec335efe00fdc9751 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-05 | 184 | 95 | 5 | d1ea2b60fb1ca1a0b809d131310c43903a9e84ce | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.78e-05 | 185 | 95 | 5 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.78e-05 | 185 | 95 | 5 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| Disease | red blood cell density measurement | TET2 SP1 ANK1 SPTA1 BACH2 TRPS1 GAS6 ADGRL4 ZNF106 THBS3 PTPRC UBXN2A PLCB3 | 3.03e-06 | 880 | 91 | 13 | EFO_0007978 |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.01e-05 | 14 | 91 | 3 | DOID:10976 (biomarker_via_orthology) | |
| Disease | sinusitis (is_marker_for) | 2.24e-05 | 18 | 91 | 3 | DOID:0050127 (is_marker_for) | |
| Disease | anorectal malformation | 2.65e-05 | 19 | 91 | 3 | MONDO_0019938 | |
| Disease | gout | 3.32e-05 | 196 | 91 | 6 | EFO_0004274 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.86e-05 | 61 | 91 | 4 | DOID:3587 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.67e-05 | 64 | 91 | 4 | DOID:4947 (is_marker_for) | |
| Disease | Sensorineural Hearing Loss (disorder) | 4.81e-05 | 23 | 91 | 3 | C0018784 | |
| Disease | Hereditary elliptocytosis | 5.62e-05 | 4 | 91 | 2 | cv:C0013902 | |
| Disease | hereditary spherocytosis type 1 (implicated_via_orthology) | 5.62e-05 | 4 | 91 | 2 | DOID:0110916 (implicated_via_orthology) | |
| Disease | Hyaloideoretinal degeneration of Wagner | 5.62e-05 | 4 | 91 | 2 | C1840452 | |
| Disease | reticulocyte count | SP1 ANK1 POTEF SPTA1 NAB1 TRPS1 MYO1B PTPRC USP32 UBXN2A PLCB3 EPB41 | 8.79e-05 | 1045 | 91 | 12 | EFO_0007986 |
| Disease | hereditary spherocytosis (is_implicated_in) | 9.35e-05 | 5 | 91 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 9.35e-05 | 5 | 91 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 9.35e-05 | 5 | 91 | 2 | C0221409 | |
| Disease | reticulocyte measurement | SP1 ANK1 POTEF SPTA1 NAB1 TRPS1 MYO1B PTPRC USP32 UBXN2A PLCB3 EPB41 | 9.44e-05 | 1053 | 91 | 12 | EFO_0010700 |
| Disease | Craniofacial Abnormalities | 1.25e-04 | 156 | 91 | 5 | C0376634 | |
| Disease | Elliptocytosis, Hereditary | 1.40e-04 | 6 | 91 | 2 | C0013902 | |
| Disease | mean corpuscular hemoglobin concentration | SP1 ANK1 POTEF SPTA1 BACH2 NAB1 MYO1B ADGRL4 THBS3 PTPRC PLCB3 EPB41 | 1.48e-04 | 1105 | 91 | 12 | EFO_0004528 |
| Disease | influenza A (H1N1) | 1.55e-04 | 87 | 91 | 4 | EFO_1001488 | |
| Disease | cancer antigen 15.3 measurement | 1.96e-04 | 7 | 91 | 2 | EFO_0010585 | |
| Disease | hemoglobin A1 measurement | 2.08e-04 | 520 | 91 | 8 | EFO_0007629 | |
| Disease | Hereditary spherocytosis | 2.60e-04 | 8 | 91 | 2 | C0037889 | |
| Disease | R-6-hydroxywarfarin measurement | 4.36e-04 | 114 | 91 | 4 | EFO_0803327 | |
| Disease | Sensory hearing loss | 5.08e-04 | 11 | 91 | 2 | C1691779 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 5.08e-04 | 11 | 91 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | cystic fibrosis (is_marker_for) | 9.41e-04 | 62 | 91 | 3 | DOID:1485 (is_marker_for) | |
| Disease | Myopia | 9.62e-04 | 15 | 91 | 2 | C0027092 | |
| Disease | melanoma | 1.04e-03 | 248 | 91 | 5 | C0025202 | |
| Disease | lymphocyte percentage of leukocytes | 1.05e-03 | 665 | 91 | 8 | EFO_0007993 | |
| Disease | myopia (is_implicated_in) | 1.10e-03 | 16 | 91 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | serum IgG glycosylation measurement | 1.19e-03 | 523 | 91 | 7 | EFO_0005193 | |
| Disease | erythrocyte measurement | 1.22e-03 | 257 | 91 | 5 | EFO_0005047 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.24e-03 | 17 | 91 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 1.24e-03 | 17 | 91 | 2 | DOID:11984 (is_marker_for) | |
| Disease | Nonorganic psychosis | 1.28e-03 | 69 | 91 | 3 | C0349204 | |
| Disease | glucagon measurement | 1.34e-03 | 154 | 91 | 4 | EFO_0008463 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.44e-03 | 157 | 91 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.48e-03 | 702 | 91 | 8 | C0009402 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.55e-03 | 19 | 91 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | facial attractiveness measurement | 1.55e-03 | 19 | 91 | 2 | EFO_0009892 | |
| Disease | Schizophrenia | 1.62e-03 | 883 | 91 | 9 | C0036341 | |
| Disease | Disproportionate short stature | 1.76e-03 | 77 | 91 | 3 | C0878659 | |
| Disease | lymphocyte count | COL2A1 TET2 ANK1 PCDHGA11 POTEF SPTA1 BACH2 GAS6 PTPRT ADGRL4 PTPRC UBXN2A | 1.78e-03 | 1464 | 91 | 12 | EFO_0004587 |
| Disease | S-7-hydroxywarfarin to S-warfarin ratio measurement | 2.03e-03 | 81 | 91 | 3 | EFO_0803334 | |
| Disease | Leukemia, Myelocytic, Acute | 2.05e-03 | 173 | 91 | 4 | C0023467 | |
| Disease | breast cancer, COVID-19 | 2.09e-03 | 22 | 91 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | triacylglycerol 58:9 measurement | 2.09e-03 | 22 | 91 | 2 | EFO_0010443 | |
| Disease | nephrosis (biomarker_via_orthology) | 2.09e-03 | 22 | 91 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | sensory peripheral neuropathy, remission | 2.28e-03 | 23 | 91 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | Pseudoaphakia | 2.48e-03 | 24 | 91 | 2 | C0524524 | |
| Disease | Lens Opacities | 2.48e-03 | 24 | 91 | 2 | C1510497 | |
| Disease | response to radiation | 2.58e-03 | 88 | 91 | 3 | GO_0009314 | |
| Disease | colon adenocarcinoma (is_marker_for) | 2.69e-03 | 25 | 91 | 2 | DOID:234 (is_marker_for) | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 2.69e-03 | 25 | 91 | 2 | DOID:0050589 (implicated_via_orthology) | |
| Disease | diet measurement, bilirubin measurement | 2.91e-03 | 26 | 91 | 2 | EFO_0004570, EFO_0008111 | |
| Disease | Prostatic Neoplasms | 2.98e-03 | 616 | 91 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.98e-03 | 616 | 91 | 7 | C0376358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TNDGTVCIENVNANC | 101 | Q9HBW9 | |
| INSGQQEPQQEESCQ | 26 | P11171 | |
| AEQNIAASQCAVGEN | 751 | Q9BYV9 | |
| CVANSAVILQNNEFG | 246 | O71037 | |
| CVANSAVILQNNEFG | 246 | Q902F8 | |
| AADIAQTQGFQECAQ | 161 | Q9NXR5 | |
| GENSAGQCAVANQQY | 116 | Q96Q42 | |
| HLRNGVDINTCNQNG | 31 | P16157 | |
| AAEAQNHCNQNGGNL | 46 | Q9NPY3 | |
| VNGVTYQQNCQAGLV | 451 | Q9BZP6 | |
| GNIQVSCVECSNQQG | 56 | Q8TDJ6 | |
| AEGAPRQENCGAQQV | 251 | Q96G46 | |
| QQNVDQAVATLQGEG | 66 | Q9BTZ2 | |
| CAGGSQVQAVECRNQ | 841 | Q9H324 | |
| QDVQEAGSCVQDGQR | 26 | P02458 | |
| KQGVNCLESQGQNTA | 436 | Q8N428 | |
| NTEGQCGTCTNNQRD | 5216 | Q9HC84 | |
| QDFDGQVVQVACGQD | 226 | Q96I51 | |
| GANQSGNRNCLQVLN | 106 | Q7Z6M1 | |
| NVQDQDSGENGQVSC | 371 | Q9Y5H2 | |
| QAQEQELCRAQGQQE | 506 | Q6DT37 | |
| AGLCVDQQDVQDGNT | 151 | Q6IWH7 | |
| GCQQQEGGGENTNSI | 176 | P26367 | |
| CNVNIFDAIAEIGNQ | 516 | P14780 | |
| QNDTQKQFCEEQNTG | 596 | A5A3E0 | |
| QQNVDQAVATLQGEG | 66 | Q6PKH6 | |
| NGERDGSLCQQQNEH | 501 | Q8IVH8 | |
| AQQGSNSCQLNNGGC | 1831 | Q9NZR2 | |
| SQNVDCQININGELE | 426 | P46934 | |
| CGQTLQAQQQGDTPA | 551 | Q06455 | |
| IQQGGDDVQQLCEAG | 31 | Q13506 | |
| FIQQGGDDVQQLCEA | 61 | Q15742 | |
| AVGRGVAEQQQQQGC | 301 | Q13201 | |
| VAEQQQQQGCGDPEV | 306 | Q13201 | |
| QQNVDQAVATLQGEG | 66 | P0CG22 | |
| SGQETEIQQVNSNCL | 286 | Q8IY21 | |
| LDQASQGQVQGLCGN | 516 | Q02817 | |
| EGLQNASQDVNSCQD | 3111 | Q02505 | |
| ADQFCNAIGVLQQCG | 16 | Q13503 | |
| GSLDFQCNVNTGQCN | 1066 | P24043 | |
| AENICEQNCTQLNEG | 3971 | P98164 | |
| KQLSCVANQNGSQAD | 761 | P23229 | |
| VANQNGSQADCELGN | 766 | P23229 | |
| CVANSAVILQNNEFG | 1006 | P63135 | |
| AGQCQELQSCQVAAD | 216 | Q7Z442 | |
| VEVNVGQNATFQCIA | 201 | O14522 | |
| GDVEVNAGQNASFQC | 196 | Q92729 | |
| CQAYVNQGENLETDQ | 121 | Q86YD1 | |
| QQQQEQKGDAPTCGI | 111 | Q9UQ26 | |
| QNDTQKQFCEEQNTG | 596 | Q6S8J3 | |
| AGQNVERECSQQAQQ | 1266 | Q460N5 | |
| QAGQETCQDTQSQQL | 886 | Q01970 | |
| VLCDNGDSIQQVQAD | 1256 | A1KZ92 | |
| QGCASTQVESENNQE | 116 | Q96HJ3 | |
| GTEERNGQNKSCQNI | 1841 | Q9H799 | |
| CVANSAVILQNNEFG | 246 | P61570 | |
| CVANSAVILQNNEFG | 246 | Q69384 | |
| TGNEEQACNHQNNGR | 171 | Q8TBM8 | |
| DVNECSQENGGCLQI | 156 | Q14393 | |
| ELCQGQEAFVQQSQN | 231 | H7C350 | |
| NGFATQEEETVNCQG | 66 | Q8N1P7 | |
| IKNGVDINICNQNGL | 61 | Q12955 | |
| EIAQNGNNDQSITEC | 3381 | Q12955 | |
| GQDQDCFQLQNTFGS | 1806 | Q8TEP8 | |
| RVAQGAACDGVQQDQ | 56 | Q96LR7 | |
| CVANSAVILQNNEFG | 246 | Q902F9 | |
| AGELQAQVENNQCIS | 311 | A8MQT2 | |
| LDVDECQDNNGGCQQ | 116 | Q8IWY4 | |
| AQVCQALAQVDGGAN | 161 | P36551 | |
| QCTLSDQNAQGQGPE | 1466 | Q12923 | |
| VQGANGLCSVDQGVQ | 1276 | Q9BZA8 | |
| QNLICNETNQSGQFE | 171 | Q6ZR62 | |
| NVCQACAREVLGQQG | 51 | Q7Z4K8 | |
| DVQQQIAQAQQGEGG | 1291 | Q8NF91 | |
| QEQVACVCEVLQQGG | 11 | Q15475 | |
| QNDTQKQFCEEQNTG | 596 | P0CG38 | |
| QLQFAATGAQVQQDG | 186 | P08047 | |
| QDQCGQQGSCLVYQN | 646 | Q96BD0 | |
| QQEQQQAACRLLEGC | 71 | E9PGG2 | |
| NSQGENCVVLVYNQD | 176 | Q8WXI8 | |
| QDVCASLQEDNGVQI | 491 | Q96M02 | |
| QGNNNNFQTEAICLV | 111 | Q9BQY6 | |
| TEETGQAQSGQANCQ | 161 | Q9UHF7 | |
| DGLGNEVSALNQQCN | 491 | O94967 | |
| EVSALNQQCNGSKGN | 496 | O94967 | |
| QCGAQGVQVQLVQDD | 786 | Q2QGD7 | |
| TEEGECQSLVQNGHQ | 141 | Q68D42 | |
| TGCINATQAANQGEF | 106 | Q9UKY0 | |
| ESCEQIAVQVNNGDA | 246 | P23497 | |
| CETGSDNQPLGNNQQ | 16 | P68543 | |
| QANACQQQQAAPVEG | 961 | P02549 | |
| AESANVCGSQQGRGQ | 46 | P40126 | |
| QVCNDIDECNDGNNG | 366 | P49746 | |
| QEQVACVCEVLQQGG | 11 | Q9NPC8 | |
| EVLQAQGQNEAAVDC | 821 | Q9ULT0 | |
| CQQGQGAEINAISEN | 226 | P35442 | |
| QNNCVNRNDIQTAGT | 481 | Q6N021 | |
| ENVECGNNTCTNNEV | 256 | P08575 | |
| QVEGEGQIFQLNCTV | 801 | O95185 | |
| ENQNSQESNGEGNCL | 966 | Q9H2Y7 | |
| DATQQQQQVAACEGR | 361 | Q96SA4 | |
| NTSDNNNQCLLGANG | 496 | Q8NFA0 | |
| EEQKNFQATLGGCQQ | 136 | P52741 | |
| QRNVSQVQDFGEGCE | 491 | Q9Y2L8 | |
| NNAIICDLIENNTNG | 441 | O43795 | |
| ETGNVQAQGCQDPNQ | 151 | Q86W25 |